KEVZARA offers every-2-week dosing, is available in 2 doses and 2 devices, and can be kept at room temperature for up to 14 days.1,2
|Low absolute neutrophil count (cells/mm3)|
|ANC >1000||Maintain current dosage of KEVZARA.|
|ANC 500-1000||Hold treatment with KEVZARA until ANC >1000. KEVZARA can then be resumed at 150 mg every 2 weeks and increased to 200 mg every 2 weeks as clinically appropriate.|
|ANC <500||Discontinue KEVZARA.|
|Low platelet count (cells/mm3)|
|50,000-100,000||Hold treatment with KEVZARA until platelets >100,000. KEVZARA can then be resumed at 150 mg every 2 weeks and increased to 200 mg every 2 weeks as clinically appropriate.|
|<50,000||If conﬁrmed by repeat testing, discontinue KEVZARA.|
|Liver enzyme abnormalities|
|ALT >1 to ≤ 3 x ULN||Consider dosage modiﬁcation of concomitant DMARDs as clinically appropriate..|
|ALT >3 to ≤ 5 x ULN||Hold treatment with KEVZARA until ALT <3 x ULN. KEVZARA can then be resumed at 150 mg every 2 weeks and increased to 200 mg every 2 weeks as clinically appropriate.|
|ALT >5 x ULN||Discontinue KEVZARA.|
MTX=methotrexate; DMARDs=disease-modifying antirheumatic drugs; ANC=absolute neutrophil count; ALT=alanine aminotransferase; AST=aspartate aminotransferase; ULN=upper limit of normal.
The pre-filled, button-free KEVZARA pen
OF PATIENTS WERE SATISFIED TO VERY SATISFIED
WITH THE KEVZARA PEN
OF PATIENTS WERE VERY TO EXTREMELY CONFIDENT THAT THEY WOULD BE ABLE TO GIVE THEMSELVES INJECTIONS WITH THE KEVZARA PEN AFTER THIS STUDY
OF PATIENTS FOUND THE KEVZARA
PEN EASY TO VERY EASY TO USE
KEVZARA is available by prescription only.
KEVZARA comes in a pre-filled syringe or a pre-filled, button-free pen.
Both should be refrigerated, but either can be kept at room temperature
(≤77°F) for up to 14 days, if needed.1,2